BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17559812)

  • 21. The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites.
    Campanero MR; Herrero A; Calvo V
    Oncogene; 2008 Feb; 27(9):1263-72. PubMed ID: 17724474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of misfolded nuclear receptor corepressor confers resistance to unfolded protein response-induced apoptosis.
    Ng AP; Howe Fong J; Sijin Nin D; Hirpara JL; Asou N; Chen CS; Pervaiz S; Khan M
    Cancer Res; 2006 Oct; 66(20):9903-12. PubMed ID: 17047052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
    Ropero S; Fraga MF; Ballestar E; Hamelin R; Yamamoto H; Boix-Chornet M; Caballero R; Alaminos M; Setien F; Paz MF; Herranz M; Palacios J; Arango D; Orntoft TF; Aaltonen LA; Schwartz S; Esteller M
    Nat Genet; 2006 May; 38(5):566-9. PubMed ID: 16642021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors.
    Hong W; Baniahmad A; Li J; Chang C; Gao W; Liu Y
    FEBS Lett; 2009 Aug; 583(15):2451-6. PubMed ID: 19595997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes.
    Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K
    J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
    Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
    Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina.
    Wallace DM; Cotter TG
    J Neurosci Res; 2009 Mar; 87(4):887-905. PubMed ID: 18951482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of transcription at the human T-cell receptor Vbeta2.2 segment is mediated by a MAX/MAD/mSin3 complex acting as a scaffold for HDAC activity.
    Font MP; Cubizolles M; Dombret H; Cazes L; Brenac V; Sigaux F; Buckle M
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1021-9. PubMed ID: 15541391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy.
    Ontoria JM; Altamura S; Di Marco A; Ferrigno F; Laufer R; Muraglia E; Palumbi MC; Rowley M; Scarpelli R; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P
    J Med Chem; 2009 Nov; 52(21):6782-9. PubMed ID: 19888759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
    Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
    Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of histone deacetylase 4 causes segregation defects during mitosis of p53-deficient human tumor cells.
    Cadot B; Brunetti M; Coppari S; Fedeli S; de Rinaldis E; Dello Russo C; Gallinari P; De Francesco R; Steinkühler C; Filocamo G
    Cancer Res; 2009 Aug; 69(15):6074-82. PubMed ID: 19622775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
    Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
    Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells.
    Lindström TM; Mohan AR; Johnson MR; Bennett PR
    Mol Pharmacol; 2008 Jul; 74(1):109-21. PubMed ID: 18375836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and characterization of tTS-H4: a novel transcriptional repressor that is compatible with the reverse tetracycline-controlled TET-ON system.
    Bockamp E; Christel C; Hameyer D; Khobta A; Maringer M; Reis M; Heck R; Cabezas-Wallscheid N; Epe B; Oesch-Bartlomowicz B; Kaina B; Schmitt S; Eshkind L
    J Gene Med; 2007 Apr; 9(4):308-18. PubMed ID: 17330923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage.
    Karamboulas C; Swedani A; Ward C; Al-Madhoun AS; Wilton S; Boisvenue S; Ridgeway AG; Skerjanc IS
    J Cell Sci; 2006 Oct; 119(Pt 20):4305-14. PubMed ID: 17038545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor.
    Ishizuka T; Lazar MA
    Mol Endocrinol; 2005 Jun; 19(6):1443-51. PubMed ID: 15695367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR).
    Cowger JJ; Torchia J
    Biochemistry; 2006 Nov; 45(44):13150-62. PubMed ID: 17073437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.